TNF overexpression and dexamethasone treatment impair chondrogenesis and bone growth in an additive manner
Abstract Children with chronic inflammation are often treated with glucocorticoids (GCs) and many of them experience growth retardation. It is poorly understood how GCs interact with inflammatory cytokines causing growth failure as earlier experimental studies have been performed in healthy animals....
Main Authors: | Yunhan Zhao, Bettina Celvin, Maria C. Denis, Niki Karagianni, Cecilia Aulin, Farasat Zaman, Lars Sävendahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-22734-8 |
Similar Items
-
Ablation of the pro-apoptotic protein Bax protects mice from glucocorticoid-induced bone growth impairment.
by: Farasat Zaman, et al.
Published: (2012-01-01) -
BMP2 and TGF-β Cooperate Differently during Synovial-Derived Stem-Cell Chondrogenesis in a Dexamethasone-Dependent Manner
by: Nikolas J. Kovermann, et al.
Published: (2019-06-01) -
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth
by: Lilly Velentza, et al.
Published: (2023-05-01) -
Bortezomib is cytotoxic to the human growth plate and permanently impairs bone growth in young mice.
by: Emma Eriksson, et al.
Published: (2012-01-01) -
A novel link between chronic inflammation and humanin regulation in children
by: Yunhan Zhao, et al.
Published: (2024-01-01)